Clinical Trial Update: Nitric Oxide in Myocardial Infarction Size [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating nitric oxide to reduce myocardial infarct size in ST-elevation myocardial infarction was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-elevation Myocardial Infarction

Drugs mentioned

• Nitric Oxide (nitric oxide)

Snippet

Sponsor: Mallinckrodt | Conditions: Acute Myocardial Infarction, ST Elevation MI | Phase 2 | Status: TERMINATED | Results posted: 2010-08-27